Debby Garbato

2 days ago | progressivegrocer.com | Debby Garbato

RMNs allows grocers to stage targeted and personalized consumer campaigns, possibly alleviating the need to invest heavily in social commerce Changes have pushed brands and retailers to innovate, integrate and heavily invest in RMNs to meet shoppers along their increasingly fragmented paths to purchase.

1 week ago | drugstorenews.com | Debby Garbato

Some deserts encompass whole counties. Others are in poor, inner cities, where many residents do not own cars and public transportation is poor. The National Library of Medicine and the U.S. Census Bureau said 20% or more of these deserts’ populations live below the poverty level. Many people are poorly educated, speak little English and/or lack health insurance.

2 months ago | drugstorenews.com | Debby Garbato

According to IQVIA, U.S. sales of liraglutide injection, 6 mg/mL, were approximately $1.3 billion in the 12 months ending October 2024. According to IQVIA, U.S. sales of liraglutide injection, 6 mg/mL, were approximately $1.3 billion in the 12 months ending October 2024. In 2025, the number of generic drug manufacturers gaining FDA approvals and launching biosimilars and GLP-1 drugs should significantly increase, along with those companies developing generics in other promising areas.

2 months ago | drugstorenews.com | Debby Garbato

According to IQVIA, U.S. sales of liraglutide injection, 6 mg/mL, were approximately $1.3 billion in the 12 months ending October 2024. According to IQVIA, U.S. sales of liraglutide injection, 6 mg/mL, were approximately $1.3 billion in the 12 months ending October 2024. In 2025, the number of generic drug manufacturers gaining FDA approvals and launching biosimilars and GLP-1 drugs should significantly increase, along with those companies developing generics in other promising areas.